CoChat

Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison

Open access
Mohamed-Ahmed, Samih, Fristad, Inge, Lie, Stein Atle, Suliman, Salwa, Mustafa, Kamal, Vindenes, Hallvard, Idris, Shaza B. · 2018 · Stem Cell Research & Therapy

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Adipose-derived stem cells (ASCs) have been introduced as an alternative to bone marrow mesenchymal stem cells (BMSCs) for cell-based therapy. However, different studies comparing ASCs and BMSCs have shown conflicting results. In fact, harvesting ASCs and BMSCs from different individuals might influence the results, making comparison difficult. Therefore, this study aimed to characterize donor-matched ASCs and BMSCs in order to investigate proliferation, differentiation potential and possible effects of donor variation on these mesenchymal stem cells (MSCs). METHODS: Human bone marrow and adipose tissue samples were obtained from nine donors aged 8-14. ASCs and BMSCs were isolated and characterized based on expression of surface markers using flow cytometry. The proliferation up to 21 days was investigated. Multi-lineage differentiation was induced using osteogenic, chondrogenic and adipogenic differentiation media. Alkaline phosphatase (ALP) activity was monitored and collagen type I formation was evaluated by immunofluorescence staining. In vitro multi-potency was studied using tissue-specific stains and lineage-specific gene expression. In addition, the osteogenic lineage was evaluated at protein level. RESULTS: Isolated ASCs and BMSCs from all donors demonstrated morphologic and immunophenotypic characteristics of MSCs, with expression of MSCs markers and negative expression of hematopoietic markers. Unlike BMSCs, ASCs showed high expression of CD49d and low expression of Stro-1. In general, ASCs showed significantly higher proliferation and adipogenic capacity with more lipid vesicle formation and expression of the adipogenesis-related genes than BMSCs. In contrast, BMSCs showed significantly higher osteogenic and chondrogenic capacity compared to ASCs. BMSCs had earlier and higher ALP activity, calcium deposition, and expression of the osteogenesis- and chondrogenesis-related genes and the osteogenesis-related protein osteopontin. Proliferation and differentiation capacity of ASCs and BMSCs varied significantly among the donors. CONCLUSIONS: ASCs and BMSCs showed tissue-specific differentiation abilities, but with significant variation between donors. The similarities and differences in the properties of ASCs and BMSCs should be taken into consideration when planning stem cell-based therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-018-0914-1

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Morphology and immunophenotype characteristics of BMSCs and ASCs. a Representative microscopic illustrations of BMSCs and ASCs. Scale bar 100 μm. b Representative histograms from the flow cytometry analysis showing surface marker expression on BMSCs and ASCs, monoclonal antibody control (blue) and the stained cells (red). c and d Percentage of surface markers expression, average of nine donors (c) and in each donor (d). Each symbol represents one donor. *p < 0.05, **p < 0.01, ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells
Fig. 1 Morphology and immunophenotype characteristics of BMSCs and ASCs. a Representative microscopic illustrations of BMSCs and ASCs. Scale bar 100 μm. b Representative histograms from the flow cytometry analysis showing surface marker expression on BMSCs and ASCs, monoclonal antibody control (blue) and the stained cells (red). c and d Percentage of surface markers expression, average of nine donors (c) and in each donor (d). Each symbol represents one donor. *p < 0.05, **p < 0.01, ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cellsCC BY · PubMed Central
Fig. 2 Proliferation of BMSCs and ASCs. a-c MTT assay at day 3, 7, 14 and 21, average of nine donors (a) and in each donor (b and c). d and e Relative gene expression of PCNA in BMSCs and ASCs at day 7, 14 and 21, average of nine donors (d) and in each donor (e). Each symbol represents one donor. **p < 0.01, ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, PCNA proliferating cell nuclear antigen
Fig. 2 Proliferation of BMSCs and ASCs. a-c MTT assay at day 3, 7, 14 and 21, average of nine donors (a) and in each donor (b and c). d and e Relative gene expression of PCNA in BMSCs and ASCs at day 7, 14 and 21, average of nine donors (d) and in each donor (e). Each symbol represents one donor. **p < 0.01, ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, PCNA proliferating cell nuclear antigenCC BY · PubMed Central
Fig. 3 ALP activity and collagen type I formation in BMSCs and ASCs. a Representative images of ALP staining of BMSCs and ASCs at day 3, 7 and 14. Scale bar 100 μm. b and c ALP activity assay of BMSCs and ASCs at day 14, average of nine donors (b) and in each donor (c). d Representative images of IF staining of collagen type I in BMSCs and ASCs at day 14. Scale bar 100 μm. Each symbol represents one donor. ALP alkaline phosphatase, ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, DAPI 4′,6-diamidino-2-phenylindole
Fig. 3 ALP activity and collagen type I formation in BMSCs and ASCs. a Representative images of ALP staining of BMSCs and ASCs at day 3, 7 and 14. Scale bar 100 μm. b and c ALP activity assay of BMSCs and ASCs at day 14, average of nine donors (b) and in each donor (c). d Representative images of IF staining of collagen type I in BMSCs and ASCs at day 14. Scale bar 100 μm. Each symbol represents one donor. ALP alkaline phosphatase, ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, DAPI 4′,6-diamidino-2-phenylindoleCC BY · PubMed Central
Fig. 4 Osteogenic gene and protein expression, and calcium deposition in BMSCs and ASCs. a and b Relative gene expression of the osteogenic genes Runx2, collagen type I, ALP and osteopontin in BMSCs and ASCs at day 7, 14 and 21, average of nine donors (a) and in each donor (b). c Western blot analysis of osteopontin in BMSCs and ASCs at day 21. d Representative images after Alizarin red S staining of BMSCs and ASCs at day 21 and 28. Scale bar 100 μm. e and f Quantification of Alizarin red S staining of BMSCs and ASCs at day 21 and 28, average of nine donors (e) and in each donor (f). Each symbol represents one donor. **p < 0.01, ***p < 0.001. ALP alkaline phosphatase, ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, Runx2 runt-related transcription factor 2
Fig. 4 Osteogenic gene and protein expression, and calcium deposition in BMSCs and ASCs. a and b Relative gene expression of the osteogenic genes Runx2, collagen type I, ALP and osteopontin in BMSCs and ASCs at day 7, 14 and 21, average of nine donors (a) and in each donor (b). c Western blot analysis of osteopontin in BMSCs and ASCs at day 21. d Representative images after Alizarin red S staining of BMSCs and ASCs at day 21 and 28. Scale bar 100 μm. e and f Quantification of Alizarin red S staining of BMSCs and ASCs at day 21 and 28, average of nine donors (e) and in each donor (f). Each symbol represents one donor. **p < 0.01, ***p < 0.001. ALP alkaline phosphatase, ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, Runx2 runt-related transcription factor 2CC BY · PubMed Central
Fig. 5 Chondrogenic gene expression and cartilaginous matrix formation in BMSCs and ASCs. a and b Relative gene expression of the chondrogenic gene aggrecan in BMSCs and ASCs at day 28, average of nine donors (a) and in each donor (b). c Representative images of Alcian blue-stained sections of BMSC and ASC pellets at day 28. Scale bar 50 μm. Each symbol represents one donor. ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells
Fig. 5 Chondrogenic gene expression and cartilaginous matrix formation in BMSCs and ASCs. a and b Relative gene expression of the chondrogenic gene aggrecan in BMSCs and ASCs at day 28, average of nine donors (a) and in each donor (b). c Representative images of Alcian blue-stained sections of BMSC and ASC pellets at day 28. Scale bar 50 μm. Each symbol represents one donor. ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cellsCC BY · PubMed Central
Fig. 6 Adipogenic gene expression and lipid vesicle formation in BMSCs and ASCs. a and b Relative gene expression of the adipogenic genes LPL and PPARG in BMSCs and ASCs at day 14, average of nine donors (a) and in each donor (b). c Representative images of Oil red O stained BMSCs and ASCs at day 14. Scale bar 100 μm. d and e Quantification of Oil red O-stained BMSCs and ASCs at day 14, average of nine donors (d) and in each donor (e). Each symbol represents one donor. ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, LPL lipoprotein lipase, PPARG peroxisome proliferator activated receptor gamma
Fig. 6 Adipogenic gene expression and lipid vesicle formation in BMSCs and ASCs. a and b Relative gene expression of the adipogenic genes LPL and PPARG in BMSCs and ASCs at day 14, average of nine donors (a) and in each donor (b). c Representative images of Oil red O stained BMSCs and ASCs at day 14. Scale bar 100 μm. d and e Quantification of Oil red O-stained BMSCs and ASCs at day 14, average of nine donors (d) and in each donor (e). Each symbol represents one donor. ***p < 0.001. ASCs adipose-derived stem cells, BMSCs bone marrow-derived stem cells, LPL lipoprotein lipase, PPARG peroxisome proliferator activated receptor gammaCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 540

Metadata

Authors
Mohamed-Ahmed, S., Fristad, I., Lie, S. A., Suliman, S., Mustafa, K., Vindenes, H., & Idris, S. B.
Affiliations
University of Bergen (NO)
Corresponding author
Fristad, Inge
Venue
Stem Cell Research & Therapy
Published
2018-06-19
Volume
9
Issue
1
Pages
168-168
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2809170199
Cited by
515
References
62
Citations by year
2026: 34 · 2025: 52 · 2024: 95 · 2023: 106 · 2022: 84 · 2021: 60 · 2020: 49 · 2019: 30 · 2018: 4
FWCI
20.27
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Universitetet i Bergen
  • Helse Vest (912048, 302077)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
adipose-derived stem cells, bone marrow mesenchymal stem cells, donor variability, multilineage differentiation, osteogenic differentiation, chondrogenic differentiation, adipogenesis, cell proliferation, alkaline phosphatase activity, osteopontin, CD49d, STRO-1, stem cell therapy
MeSH terms
Adipose Tissue, Cell Differentiation, Humans, Tissue Donors, Cell Proliferation, Adipogenesis, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. https://app.cochat.ai/papers/10.1186/s13287-018-0914-1
The paper
Mohamed-Ahmed, S., Fristad, I., Lie, S. A., Suliman, S., Mustafa, K., Vindenes, H., & Idris, S. B. (2018). Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-018-0914-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.